InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Immunovant, Inc.

IMVT Clue Score35
United States Fiscal year ends March CIK 0001764013 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

66
Insider
Date
Role
Action
Shares
Price
Amount
Tiago Girao
28 Oct 2026
Chief Financial Officer
Sell
6,606
$28.50
$188.27K
Jay S Stout
21 Oct 2026
Chief Technology Officer
Sell
2,595
$28.94
$75.10K
Jay S Stout
7 Oct 2026
Chief Technology Officer
Sell
1,596
$32.06
$51.17K
Jay S Stout
7 Oct 2026
Chief Technology Officer
Sell
2,213
$32.06
$70.95K
Melanie Gloria
7 Oct 2026
Chief Operating Officer
Sell
2,241
$32.06
$71.85K
Tuyl Christopher Van
7 Oct 2026
Chief Legal Officer
Sell
1,327
$32.06
$42.54K
Eric Venker
2 Oct 2026
Chief Executive Officer
Sell
3,506
$34.11
$119.59K
Eric Venker
1 Oct 2026
Chief Executive Officer
Exercised, kept
92,187
$14.46
$1.33M
Tuyl Christopher Van
23 Sep 2026
Chief Legal Officer
Sell
2,846
$36.36
$103.48K
Atul Pande
28 Aug 2026
Director
Sold after exercise
1,500
$43.27
$64.91K
Melanie Gloria
20 Aug 2026
Chief Operating Officer
Sell
3,056
$44.16
$134.95K
Atul Pande
24 Jul 2026
Director
Sold after exercise
1,500
$39.80
$59.70K
Jay S Stout
23 Jul 2026
Chief Technology Officer
Sell
2,857
$38.69
$110.54K
Tiago Girao
23 Jul 2026
Chief Financial Officer
Sell
6,798
$38.69
$263.01K
Jay S Stout
8 Jul 2026
Chief Technology Officer
Sell
77
$39.99
$3.08K
Jay S Stout
8 Jul 2026
Chief Technology Officer
Sell
1,399
$39.53
$55.30K
Jay S Stout
8 Jul 2026
Chief Technology Officer
Sell
105
$39.99
$4.20K
Jay S Stout
8 Jul 2026
Chief Technology Officer
Sell
1,906
$39.53
$75.34K
Tuyl Christopher Van
8 Jul 2026
Chief Legal Officer
Sell
63
$39.99
$2.52K
Tuyl Christopher Van
8 Jul 2026
Chief Legal Officer
Sell
1,143
$39.53
$45.18K
Melanie Gloria
8 Jul 2026
Chief Operating Officer
Sell
106
$39.99
$4.24K
Melanie Gloria
8 Jul 2026
Chief Operating Officer
Sell
1,930
$39.53
$76.29K
Eric Venker
2 Jul 2026
Chief Executive Officer
Sell
3,092
$38.48
$118.98K
Eric Venker
1 Jul 2026
Chief Executive Officer
Exercised, kept
92,188
$14.46
$1.33M
Atul Pande
26 Jun 2026
Director
Sold after exercise
1,500
$38.01
$57.02K
Tiago Girao
26 Jun 2026
Chief Financial Officer
Sold after exercise
10,000
$38.46
$384.60K
Tuyl Christopher Van
26 Jun 2026
Chief Legal Officer
Sold after exercise
2,842
$38.96
$110.72K
Tuyl Christopher Van
26 Jun 2026
Chief Legal Officer
Sold after exercise
14,982
$38.19
$572.16K
Jay S Stout
26 Jun 2026
Chief Technology Officer
Sell
6,723
$38.94
$261.79K
Jay S Stout
26 Jun 2026
Chief Technology Officer
Sell
33,277
$38.18
$1.27M
Melanie Gloria
26 Jun 2026
Chief Operating Officer
Sell
2,966
$38.95
$115.53K
Melanie Gloria
26 Jun 2026
Chief Operating Officer
Sell
14,748
$38.18
$563.08K
Tuyl Christopher Van
18 Jun 2026
Chief Legal Officer
Sell
2,634
$35.39
$93.22K
Atul Pande
15 Jun 2026
Director
Sold after exercise
1,500
$34.02
$51.03K
Andrew J. Fromkin
28 May 2026
Director
Sold after exercise
210,468
$33.56
$7.06M
Andrew J. Fromkin
28 May 2026
Director
Sold after exercise
11,483
$32.64
$374.81K
Atul Pande
20 May 2026
Director
Sold after exercise
6,000
$32.00
$192.00K
Melanie Gloria
20 May 2026
Chief Operating Officer
Sell
1,698
$32.95
$55.95K
Melanie Gloria
20 May 2026
Chief Operating Officer
Sell
1,168
$32.15
$37.55K
Melanie Gloria
20 May 2026
Chief Operating Officer
Sell
249
$30.41
$7.57K
Robert Graham Susman
1 May 2026
Director
Sold on a plan
2,502
$27.17
$67.98K
Jay S Stout
23 Apr 2026
Chief Technology Officer
Sell
2,754
$29.62
$81.57K
Tiago Girao
23 Apr 2026
Chief Financial Officer
Sell
25,760
$29.62
$763.01K
Jay S Stout
8 Apr 2026
Chief Technology Officer
Sell
1,518
$24.83
$37.69K
Jay S Stout
8 Apr 2026
Chief Technology Officer
Sell
8,614
$24.83
$213.89K
Melanie Gloria
8 Apr 2026
Chief Operating Officer
Sell
8,722
$24.83
$216.57K
Tuyl Christopher Van
8 Apr 2026
Chief Legal Officer
Sell
5,165
$24.83
$128.25K
Eric Venker
2 Apr 2026
Chief Executive Officer
Sell
1,409
$24.60
$34.66K
Eric Venker
2 Apr 2026
Chief Executive Officer
Sell
12,820
$24.04
$308.19K
Eric Venker
1 Apr 2026
Chief Executive Officer
Exercised, kept
368,750
$14.46
$5.33M
Tuyl Christopher Van
18 Mar 2026
Chief Legal Officer
Sell
2,877
$24.97
$71.84K
Melanie Gloria
25 Feb 2026
Chief Operating Officer
Sell
942
$28.90
$27.22K
Melanie Gloria
25 Feb 2026
Chief Operating Officer
Sell
859
$28.16
$24.19K
Melanie Gloria
25 Feb 2026
Chief Operating Officer
Sell
1,437
$26.98
$38.77K
Jay S Stout
21 Jan 2026
Chief Technology Officer
Sell
1,977
$26.03
$51.46K
Jay S Stout
7 Jan 2026
Chief Technology Officer
Sell
55
$26.92
$1.48K
Jay S Stout
7 Jan 2026
Chief Technology Officer
Sell
1,148
$26.51
$30.43K
Tuyl Christopher Van
18 Dec 2025
Chief Legal Officer
Sell
2,284
$27.38
$62.54K
Tuyl Christopher Van
18 Dec 2025
Chief Legal Officer
Sell
8,529
$26.78
$228.41K
Roivant Sciences Ltd.
12 Dec 2025
Director
Buy
16,666,666
$21.00
$350.00M
Douglas J. Hughes
1 Dec 2025
Director
Sold on a plan
1,909
$23.96
$45.74K
Douglas J. Hughes
1 Dec 2025
Director
Sold on a plan
13,091
$23.14
$302.93K
Andrew J. Fromkin
1 Dec 2025
Director
Sold on a plan
2,898
$23.95
$69.41K
Andrew J. Fromkin
1 Dec 2025
Director
Sold on a plan
19,351
$23.14
$447.78K
Melanie Gloria
20 Nov 2025
Chief Operating Officer
Sell
2,375
$23.97
$56.93K
Melanie Gloria
20 Nov 2025
Chief Operating Officer
Sell
10,251
$23.54
$241.31K

What was left out

Form 4 filings counted 53
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 10
Sales at will 47
Transactions with no price 0
Shares from compensation/vesting 2,029,785
History held since 15 May 2019